Fortress Biotech Inc (FBIO) — Working Capital to Net Assets Ratio
Fortress Biotech Inc (FBIO) has a Working Capital to Net Assets ratio of 119.2% as of December 2025. Working capital of $74.10 Million (current assets of $123.84 Million minus current liabilities of $49.74 Million) is measured against net assets of $62.18 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see how large is Fortress Biotech Inc's balance sheet.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Fortress Biotech Inc Working Capital to Net Assets (2009–2025)
This chart shows how Fortress Biotech Inc's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of December 2025, the ratio stands at 119.2%, reflecting working capital of $74.10 Million against net assets of $62.18 Million USD. Explore Fortress Biotech Inc (FBIO) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for Fortress Biotech Inc (2009–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Fortress Biotech Inc from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Explore Fortress Biotech Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 119.2% | $74.10 Million | $62.18 Million | $123.84 Million | $49.74 Million | ▲ +1273.2 pp |
| 2024 | -1154.0% | $18.97 Million | $-1.64 Million | $90.37 Million | $71.40 Million | ▼ -3177.6 pp |
| 2023 | 2023.6% | $32.11 Million | $1.59 Million | $117.02 Million | $84.91 Million | ▲ +1818.2 pp |
| 2022 | 205.3% | $102.72 Million | $50.02 Million | $230.43 Million | $127.72 Million | ▲ +96.7 pp |
| 2021 | 108.7% | $245.42 Million | $225.88 Million | $346.46 Million | $101.04 Million | ▼ -0.2 pp |
| 2020 | 108.8% | $214.39 Million | $197.00 Million | $266.15 Million | $51.76 Million | ▼ -43.7 pp |
| 2019 | 152.5% | $110.64 Million | $72.53 Million | $156.25 Million | $45.62 Million | ▼ -129.0 pp |
| 2018 | 281.6% | $55.59 Million | $19.74 Million | $111.21 Million | $55.61 Million | ▲ +188.9 pp |
| 2017 | 92.7% | $111.74 Million | $120.50 Million | $183.18 Million | $71.44 Million | ▲ +28.8 pp |
| 2016 | 64.0% | $53.07 Million | $82.97 Million | $109.63 Million | $56.56 Million | ▼ -41.9 pp |
| 2015 | 105.8% | $89.20 Million | $84.27 Million | $99.78 Million | $10.58 Million | ▲ +11.7 pp |
| 2014 | 94.1% | $66.39 Million | $70.52 Million | $70.46 Million | $4.08 Million | ▼ -15.1 pp |
| 2013 | 109.3% | $88.82 Million | $81.28 Million | $100.03 Million | $11.21 Million | ▼ -51.7 pp |
| 2012 | 160.9% | $35.46 Million | $22.03 Million | $40.59 Million | $5.13 Million | ▲ +57.0 pp |
| 2011 | 103.9% | $19.88 Million | $19.13 Million | $23.38 Million | $3.49 Million | ▲ +4.1 pp |
| 2010 | 99.8% | $13.36 Million | $13.38 Million | $14.92 Million | $1.56 Million | ▲ +3.8 pp |
| 2009 | 96.1% | $-9.69 Million | $-10.09 Million | $1.51 Million | $11.21 Million | — |